Impact of TRMT6 on prognosis and immune microenvironment in ovarian cancer
The findings suggest that the m1A regulator TRMT6 may drive ovarian cancer progression by promoting immune escape.
Authors
- Yazhuo Wang (ORCID: https://orcid.org/0000-0003-3952-9553)
- Na Li (ORCID: https://orcid.org/0000-0003-0178-4743)
- Jing Zhao (ORCID: https://orcid.org/0000-0001-6981-0042)
- Xiaona Wang (ORCID: https://orcid.org/0000-0002-5724-3025)
Institutions
- Hebei General Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-30
- DOI
- https://doi.org/10.3389/fonc.2025.1636191
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00